tradingkey.logo
tradingkey.logo

Viridian's thyroid eye disease drug succeeds in late‑stage trial

ReutersMar 30, 2026 11:07 AM

- Viridian Therapeutics VRDN.O said on Monday its experimental drug met the main goal when tested in patients with active thyroid eye disease in late-stage study.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI